In December, the World Health Organization said that just a single dose of the HPV jab will offer full protection. Firms in China and India are now producing their country's first domestic HPV jabs. The price of those vaccines is also expected to be well below the current market rate. This should supply the Indian government's first national HPV vaccination effort.
Hints of the long campaign ahead are emerging, but all the operations so far are just drawing the eventual, full-scale battle lines. Cheap vaccinations could save millions of lives lost to cervical cancer; we ask why and where jab rates are falling. And why airlines have more money tied up in Nigeria than in the rest of the world combined.
For full access to print, digital and audio editions of The Economist, try a free 30-day digital subscription by going to www.economist.com/intelligenceoffer